OrbiMed is a healthcare investment firm that provides tailored financing solutions and global team resources to help build world-class healthcare companies.

OrbiMed

OrbiMed invests globally across the healthcare industry, from start-ups to large multinational corporations, through a range of private equity funds, public equity funds, and royalty/credit funds. OrbiMed seeks to be a capital provider of choice, providing tailored financing solutions and extensive global team resources to help build world-class healthcare companies. OrbiMed’s team of over 100 professionals is based in New York City, San Francisco, Shanghai, Hong Kong, Mumbai, Herzliya, and other key global markets.

Zai Lab

LogicBio Therapeutics

Magenta Therapeutics

BiolineRx

Century Therapeutics

Constellation Pharmaceuticals

Crinetics Pharmaceuticals

Cullinan Oncology

Erasca

Natera

Nautilus Biotechnology

Netmeds

NeuroPace

ORIC Pharmaceuticals

Owlet Baby Care

Terns Pharmaceuticals

Third Harmonic Bio

TigerConnect

Tricida

Valneva

VectivBio

Gelesis

Graphite Bio

Guardant Health

Health Catalyst

Imara

Insmed

Inspire Medical Systems

Intellia Therapeutics

Sierra Oncology

Puma Biotechnology

RedHill Biopharma

ReViral

scPharmaceuticals

Sientra

Syndax Pharmaceuticals

AbCellera

Acutus Medical

Invivyd

Adaptive Biotechnologies

Affimed

Alector

Alpine Immune Sciences

Amolyt Pharma

Arcutis Biotherapeutics

Ascendis Pharma

Athersys

Ventyx Biosciences

ViewRay

Augmedix

Sonendo

Invitae

Kala Pharmaceuticals

ORBI

COM:ORBIMED

OrbiMed

locale

market

industry

website

linkedin

founding date

peer of

invested in

Metrics